Glomerular Diseases Associated With Cancer, Chemotherapy, and Hematopoietic Stem Cell Transplantation

Advances in Chronic Kidney Disease

Volumn 21, Issue 1, 2014, Pages 48-55

  Jhaveri, Kenar D ^a,b   Shah, Hitesh H ^a,b   Patel, Chinmay ^a,b   Kadiyala, Aditya ^a,b   Stokes, Michael B ^a,b   Radhakrishnan, Jai ^a,b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Cancer; Chemotherapy; Graft versus host disease; Hematopoietic stem cell transplantation; Paraneoplastic glomerulonephritis

Indexed keywords

ANTINEOPLASTIC AGENT; AXITINIB; BEVACIZUMAB; CYCLOSPORIN; DAUNORUBICIN; DOXORUBICIN; EVEROLIMUS; GEMCITABINE; IMATINIB; INTERFERON; IPILIMUMAB; LENALIDOMIDE; MITOMYCIN; PAMIDRONIC ACID; PAZOPANIB; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SORAFENIB; SUNITINIB; TACROLIMUS; TEMSIROLIMUS;

CANCER CHEMOTHERAPY; CANCER SCREENING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; COLLAPSING GLOMERULOPATHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FIBRILLARY GLOMERULONEPHRITIS; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOTACTOID GLOMERULOPATHY; KIDNEY BIOPSY; LUPUS LIKE SYNDROME; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE DISEASE; NEOPLASM; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RARE DISEASE; REVIEW; RISK FACTOR; TH2 CELL; THERAPY; THROMBOTIC THROMBOCYTOPENIC PURPURA; THYMOMA;

CANCER; CHEMOTHERAPY; GRAFT VERSUS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; PARANEOPLASTIC GLOMERULONEPHRITIS;

ANTINEOPLASTIC AGENTS; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY GLOMERULUS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, NON-HODGKIN; NEOPLASMS; NEPHROSIS, LIPOID;

EID: 84890716432     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2013.08.003     Document Type: Review

References (54)

1. Galloway J. Remarks on Hodgkin's disease. Br Med J 1922, 2(3234):1201-1208.
2. Ronco P.M. Paraneoplastic glomerulonephritis: new insights into an old entity. Kidney Int 1999, 56(1):355-377.
3. Bacchetta J., Juillard L., Cochat P., Droz J.P. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol Hematol 2009, 70(1):39-58.
4. Lefaucheur C., Stengel B., Nochy D., et al. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 2006, 70(8):1510-1517.
5. Beck L.H., Bonegio R.G., Lambeau G., et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009, 361(1):11-21.
6. Qin W., Beck L.H., Zeng C., et al. Anti phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011, 22(6):1137-1143.
7. Hoxha E., Kneißler U., Stege G., et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 2012, 82(7):797-804.
8. Ohtani H., Wakui H., Komatsuda A., et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 2004, 19(3):574-579.
9. KDIGO Clinical Practice Guidelines for Glomerulonephritis. Kidney Int Suppl 2012, 2:186-197.
10. Bjorneklett R., Vikse B.E., Svarstad E., et al. Long-term risk of cancer in membranous nephropathy patients. Am J Kidney Dis 2007, 50(3):396-403.
11. Beck L.H. Membranous nephropathy and malignancy. Semin Nephrol 2010, 30(6):635-644.
12. Moulin B., Ronco P.M., Mougenot B., Francois A., Fillastre J.P., Mignon F. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int 1992, 42(1):127-135.
13. Brukamp K., Dolye A., Bloom R., et al. Nephrotic syndrome after hematopoietic stem cell transplantation: do glomerular lesions represent renal graft versus host disease?. Clin J Am Soc Nephrol 2006, 1(14):685-694.
14. Srinivasan R., Balow J.E., Sabnis S., et al. Nephrotic syndrome: anunder-recognised immune-mediated complication of non-myeloablative allogeneic hematopoietic cell transplantation. Br J Haematol 2005, 131(1):74-79.
15. Hingorani S., Guthrie K.A., Schoch G., Weiss N.S., McDonald G.B. Chronic kidney disease in long-term survivors of hematopoietic stem cell transplant. Bone Marrow Transplant 2007, 39(4):223-229.
16. Luo X.D., Liu Q.F., Zhang Y., et al. Nephrotic syndrome after allogenic hematopoietic stem cell transplantation: etiology and pathogenesis. Blood Cells Mol Dis 2011, 46(2):182-187.
17. Hu S. The role of graft versus host disease in hematopoietic cell transplantation-associated glomerular disease. Nephrol Dial Transplant 2011, 26(6):2025-2031.
18. Troxell M., Pilapil M., Miklos D., et al. Renal pathology in hematopoietic cell transplantation recipients. Mod Pathol 2008, 21(4):396-406.
19. Glezeman I., Jhaveri K.D., Watson T.H., et al. Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell depleted hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010, 16(7):976-984.
20. Mallouk A., Pham P.T., Pham P.C. Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies. Clin Exp Nephrol 2006, 10(4):284-289.
21. Audard V., Larousserie F., Grimbert P., et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of21 cases and review of the literature. Kidney Int 2006, 69(12):2251-2260.
22. Kuppers R., Schwering I., Brauninger A., Rajewsky K., Hansmann M.L. Biology of Hodgkin's lymphoma. Ann Oncol 2002, 13(suppl 1):11-18.
23. Lai K.W., Wei C.L., Tan L.K., et al. Overexpression of interleukin-13 induces minimal change like nephropathy in rats. J Am Soc Nephrol 2007, 18(5):1476-1485.
24. Grimbert P., Valanciute A., Audard V., et al. Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J Exp Med 2003, 198(5):797-807.
25. Audard V., Zhang S.Y., Copie-Bergman C., et al. Occurrence of minimal change nephrotic syndrome in classical Hodgkin-Reed Sternberg cells and podocytes. Blood 2010, 115(18):3756-3762.
26. Karras A., de Montpreville V., Fakhouri F., Grunfeld J.P., Lesavre P. Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant 2005, 20(6):1075-1082.
27. Taniguchi K., Fujioka H., Torashima Y., Yamaguchi J., Izawa K., Kanematsu T. Rectal cancer with paraneoplastic nephropathy: association of vascular endothelial growth factor. Dig Surg 2004, 21(5-6):455-457.
28. Hirokawa K., Utsuyama M., Kasai M., Konno A., Kurashima C., Moriizumi E. Age related hyperplasia of the thymus and T cell system in the Buffalo rat, Immunological and immunhistological studies. Virchows Arch B Cell Pathol Incl Mol Pathol 1990, 59(1):38-47.
29. Le Berre L., Bruneau S., Naulet J., et al. Induction of T regulartory cells attenuates idiopathic nephrotic syndrome. J Am Soc Nephrol 2009, 20(1):57-67.
30. Le Berre L., Hervé C., Buzelin F., Usal C., Soulillou J.P., Dantal J. Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int 2005, 68(5):2079-2090.
31. Thaunat O., Delahousse M., Fakhouri F., et al. Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int 2006, 69(10):1892-1898.
32. Au W.Y., Chan K.W., Lui S.L., Lam C.C., Kwong Y.L. Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders. Am J Kidney Dis 1999, 34(5):889-893.
33. Said S., Leung N., Sethi S., et al. Myeloproliferative neoplasms cause glomerulopathy. Kidney Int 2011, 80(7):753-759.
34. Gersuk G.M., Carmel R., Pattengale P.K. Platelet-derived growth factor concentrations in platelet- poor plasma and urine from patients with myeloproliferative disorders. Blood 1989, 74(7):2330-2334.
35. Floege J., Eitner F., Alpers C.E. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008, 19(1):12-23.
36. Kosch M., August C., Hausberg M., et al. Focal sclerosis with tip lesions secondary to polycythaemia vera. Nephrol Dial Transplant 2000, 15(10):1710-1711.
37. Okuyama S., Hamai K., Fujishima M., et al. Focal segmental glomerulosclerosis associated with polycythemia vera: report of a case and review of the literature. Clin Nephrol 2007, 68(6):412-415.
38. Da'as N., Pollack A., Cohen Y., et al. Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 2001, 67(3):158-164.
39. Sethi S., Zand L., Leung N., et al. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 2010, 5(5):770-782.
40. Magyarlaki T., Kiss B., Buzogany I., Fazekas A., Sukosd F., Nagy J. Renal cell carcinoma and paraneoplastic IgA nephropathy. Nephron 1999, 82(2):127-130.
41. Mustonen J., Pasternack A., Helin H. IgA mesangial nephropathy in neoplastic diseases. Contrib Nephrol 1984, 40(3):283-291.
42. Bajel A., Yin Lin M., Hill P.A., et al. IgA nephropathy associated with cutaneous T cell lymphoma. Leuk Lymphoma 2009, 50(12):2083-2085.
43. Pertuiset E., Liote F., Launay-Russ E., Kemiche F., Cerf-Payrastre I., Chesneau A.M. Adult Henoch-Schonlein purpura associated with malignancy. Semin Arthritis Rheum 2000, 29(6):360-367.
44. Zurada J.M., Ward K.M., Grossman M.E. Henoch-Schönlein purpura associated with malignancy in adults. J Am Acad Dermatol 2006, 55(suppl 5):S65-S70.
45. Pillebout E., Thervet E., Hill G., Alberti C., Vanhille P., Nochy D. Henoch-Schonlein purpura in adults: outcomes and prognostic factors. J Am Soc Nephrol 2002, 13(5):1271-1278.
46. Werner T.L., Agarwal N., Carney H.M., Rodgers G.M. Management of cancer-associated thrombotic microangiopathy: what is the right approach?. Am J Hematol 2007, 82(4):295-298.
47. Francis K.K., Kalyanam N., Terrell D.R., Vesely S.K., George J.N. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases. Oncologist 2007, 12(1):11-19.
48. Ruutu T., Barosi G., Benjamin R.J., et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an international working group. Haematologica 2007, 92(1):95-100.
49. Chang A., Hingorani S., Kowalewska J., et al. Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients. Clin J Am Soc Nephrol 2007, 2(5):1014-1023.
50. Changsirikulchai S., Myerson D., Guthrie K.A., et al. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009, 4(2):345-353.
51. Ho V.T., Cutler C., Carter S., et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after stem cell transplantation. Biol Blood Marrow Transplant 2005, 11(8):571-575.
52. Hahn T., Alam A.R., Lawrence D., et al. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor and methylprednisolone T cell depletion. Transplantation 2004, 78(10):1515-1522.
53. Rosenstock J.L., Markowitz G.S., Valeri A.M., Sacchi G., Appel G., D'Agati V. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int 2003, 63(4):1450-1461.
54. Nasr S.H., Valeri A.M., Cornell L.D., et al. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol 2011, 6(4):775-784.